首页> 中文期刊> 《微环境与微生态学研究》 >Mesenchymal stem cells are being used in multiple diseases -Treatment prospects in COPD

Mesenchymal stem cells are being used in multiple diseases -Treatment prospects in COPD

             

摘要

Mesenchymal stem cells(MSCs)are adult stem cells with low immunogenicity and strong immune regulation ability.In addition to commonly obtained from bone marrow,umbilical cord,cord blood,and placenta,it can also be extracted from a large number of other tissues.Under different induction conditions,MSCs can differentiate into a variety of tissue cells,and have hematopoietic support,immune regulation,tissue repair and other functions.In addition,MSCs also have immunomodulatory,anti-inflammatory and tissue repair effects,which can reduce graft-versus-host disease and other transplant-related complications.Based on the unique immunomodulatory properties,MSCs have broad clinical application prospects.Especially for the treatment of inflammatory diseases,the treatment of multiple system diseases has been involved.Regarding the treatment of COVID-19,a number of clinical trials are also underway.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号